Viewing StudyNCT00483301



Ignite Creation Date: 2024-05-05 @ 5:36 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00483301
Status: COMPLETED
Last Update Posted: 2012-05-03
First Post: 2007-05-30

Brief Title: A Phase II Trial OF Carboplatin ABI-007 Abraxane And Sorafenib BAY 43-9006 in Metastatic Melanoma
Sponsor: Mt Sinai Medical Center Miami
Organization: Mt Sinai Medical Center Miami

Conditions & Keywords Data

Conditions:
Name
Malignant Melanoma
Keywords:
Name View
Abraxis View
Melanoma View
Abraxane View
Sorafenib View
BAY 43-9006 View